Apres-demain SA
About Debiopharm Investment / Debiopharm Investment SA pursues a mission of preserving, diversifying and supporting the sustainable growth of Debiopharm Group, a biopharmaceutical development company based in Lausanne (Switzerland), through a comprehensive investment strategy centered on three areas of activity: Finance (portfolio management, currency hedging), Real Estate (residential and commercial) and Private Equity. The Private Equity team focuses primarily on investment diversification, managing a portfolio of funds and direct equity investments, as minority shareholders, in the capital of pioneering start-ups as well as small and medium-sized European companies. Our entrepreneurial background, as well as our willingness and capacity to be long-term partners alongside the teams in which we invest, are the established pillars of our commitment.
Investments
Type of firm | Corporate Subsidiary |
Investment Stages | Buyout - Buyin, Expansion - Development Capital |
Industrial Sectors | All |
Geographical Focus | France, Switzerland, Western Europe |
Type of financing | Equity Financing, Minority Equity |
Company Profile
Number of Employees in Switzerland | 20 |
Number of Portfolio Companies | 20 |
Examples of Portfolio Companies | Haut-Lac International bilingual school, Coorpacademy |
Size of Investment | From CHF 5m to 20m depending on investment stages |